Select Medical's 15min chart sees MACD Death Cross, Bollinger Bands narrowing, KDJ Death Cross.
ByAinvest
Friday, Aug 15, 2025 11:59 am ET1min read
SEM--
The MACD Death Cross indicates a bearish trend reversal, while the KDJ Death Cross signals a shift in market sentiment, with buyers losing their grip on the market. The Bollinger Bands Narrowing further supports this bearish trend by suggesting a decline in the magnitude of price fluctuations [2].
Mizuho Financial Group recently lowered its price target for Select Medical to $18.00 from $21.00, maintaining an Outperform rating. The firm cited disappointing second-quarter 2025 earnings, with particular pressure in the company’s critical illness recovery hospital (LTCH) segment, which continues to face challenges from the Medicare high-cost outlier threshold and the 20% transmittal rule [3].
Despite these challenges, Select Medical’s inpatient rehabilitation (IRF) segment remains a bright spot in the company’s operations. Mizuho expects the IRF segment to continue driving growth for Select Medical, supporting its decision to maintain an Outperform rating despite the reduced price target [3].
Select Medical reported its second-quarter 2025 earnings, showing a mixed performance. The company achieved a significant earnings per share (EPS) of $0.60, which was a substantial 150% above the forecast of $0.24. However, the revenue fell short of expectations, coming in at $1.28 billion compared to the anticipated $1.34 billion [3].
Investors are advised to exercise caution and diligent risk management in the face of these bearish indicators. The market's current state of paralysis, awaiting the quarterly results of ICICI Bank, HDFC Bank, and Reliance Industries, scheduled for release this weekend, may further exacerbate volatility [3].
References:
[1] https://www.ainvest.com/news/nuvalent-15min-chart-shows-macd-death-cross-kdj-death-cross-2508/
[2] https://www.ainvest.com/news/bollinger-bands-narrowing-kdj-death-cross-triggered-champion-homes-15-min-chart-2507/
[3] https://za.investing.com/news/analyst-ratings/mizuho-lowers-select-medical-holdings-stock-price-target-on-ltch-segment-pressure-93CH-3831403
The 15-minute chart for Select Medical's stock has recently triggered a MACD Death Cross, Bollinger Bands Narrowing, and KDJ Death Cross as of August 15, 2025, at 11:45. This indicates that the stock price has the potential to continue falling, with a decreasing magnitude of fluctuations, and a momentum shift towards the downside, potentially leading to further decreases in value.
Select Medical (NYSE: SEM) has recently triggered several bearish indicators on its 15-minute chart, signaling potential further declines in stock price. On August 15, 2025, at 11:45, the stock experienced a MACD Death Cross, Bollinger Bands Narrowing, and KDJ Death Cross. These technical indicators suggest a momentum shift towards the downside, with a decreasing magnitude of price fluctuations [1].The MACD Death Cross indicates a bearish trend reversal, while the KDJ Death Cross signals a shift in market sentiment, with buyers losing their grip on the market. The Bollinger Bands Narrowing further supports this bearish trend by suggesting a decline in the magnitude of price fluctuations [2].
Mizuho Financial Group recently lowered its price target for Select Medical to $18.00 from $21.00, maintaining an Outperform rating. The firm cited disappointing second-quarter 2025 earnings, with particular pressure in the company’s critical illness recovery hospital (LTCH) segment, which continues to face challenges from the Medicare high-cost outlier threshold and the 20% transmittal rule [3].
Despite these challenges, Select Medical’s inpatient rehabilitation (IRF) segment remains a bright spot in the company’s operations. Mizuho expects the IRF segment to continue driving growth for Select Medical, supporting its decision to maintain an Outperform rating despite the reduced price target [3].
Select Medical reported its second-quarter 2025 earnings, showing a mixed performance. The company achieved a significant earnings per share (EPS) of $0.60, which was a substantial 150% above the forecast of $0.24. However, the revenue fell short of expectations, coming in at $1.28 billion compared to the anticipated $1.34 billion [3].
Investors are advised to exercise caution and diligent risk management in the face of these bearish indicators. The market's current state of paralysis, awaiting the quarterly results of ICICI Bank, HDFC Bank, and Reliance Industries, scheduled for release this weekend, may further exacerbate volatility [3].
References:
[1] https://www.ainvest.com/news/nuvalent-15min-chart-shows-macd-death-cross-kdj-death-cross-2508/
[2] https://www.ainvest.com/news/bollinger-bands-narrowing-kdj-death-cross-triggered-champion-homes-15-min-chart-2507/
[3] https://za.investing.com/news/analyst-ratings/mizuho-lowers-select-medical-holdings-stock-price-target-on-ltch-segment-pressure-93CH-3831403
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet